Telehealth

A new report shows 40% of ANZ firms never assess skin cancer risk, despite 84% seeing it as a duty of care, exposing a massive legal and health liability.

The health tech firm posts strong revenue and positive EBITDA, but SEC filings and a falling stock price reveal a more complex and challenging road ahead.

Chaim Indig’s third honor as a Top 50 CEO underscores Phreesia's deep impact on patient care, backed by major growth and market leadership.

Facing a national crisis of long waits for autism diagnosis, a new free online tool from Catalight hopes to connect families with care in days, not months.

Chartis reveals its 2026 Top 100 rural hospitals, highlighting resilience and innovation as hundreds of other facilities face the risk of closure.

New partnerships expand Cadence's remote patient care, using data to slash hospital visits, cut costs, and empower seniors to live healthier at home.

A surge in healthcare job applications offers a prime opportunity, but new data reveals a critical bottleneck preventing companies from turning interest into hires.

With a 135% revenue surge and a key FDA submission for its kidney transplant drug, Hansa Biopharma is poised for a pivotal year of expansion.

A major new report reveals a deepening crisis in rural healthcare, as a $50 billion federal program clashes with devastating cuts, pushing a vital system to the brink.

With a new CMO known for slashing costs and improving outcomes, Vynca is poised to expand its high-tech, high-touch model for serious illness management.

With a fresh $118M in funding, Garner Health's AI platform aims to cut healthcare costs by guiding millions of patients to top-rated doctors.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

A national report card gives the U.S. a 'B' on rare disease policy, but stark state-by-state disparities leave millions vulnerable to financial ruin.

With transplant patient needs growing, BioMatrix promotes Heidi Ulbrich to manage its services, highlighting a model built for speed and complex care.

A £500,000 philanthropic investment fuels five pioneering research projects at Oxford, aiming to unlock new treatments for a devastating rare disease.

The Detroit Pistons' groundbreaking deal with men's health platform Rugiet signals a new era in sports sponsorships, aiming to destigmatize men's wellness.

After winning a major award, OnMed's tech-enabled CareStation promises to revolutionize access to care. But can this hybrid model solve a national crisis?

With rapid trial enrollment for a novel drug, Pulmovant offers a potential lifeline for patients with PH-ILD, a condition with few to no options.

Early trial data for ABX1100 reveals a novel approach to reducing muscle damage in Pompe disease, offering hope for less burdensome treatment.

As Amwell prepares its 2025 results, investors watch to see if its strategic pivot to profitability can redefine the future of digital healthcare.